Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Myriad Genetics Inc (NQ: MYGN ) 26.61 -0.48 (-1.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 601,289 Open 26.89 Bid (Size) 25.43 (1) Ask (Size) 27.91 (1) Prev. Close 27.09 Today's Range 26.23 - 27.48 52wk Range 13.82 - 27.82 Shares Outstanding 90,500,000 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk July 17, 2024 New Nationwide Survey Findings Show That More Than Half of Women Do Not Know That Breast Density Can Reveal Increased Risk of Breast Cancer From Myriad Genetics, Inc. Via GlobeNewswire Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing July 11, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Performance YTD +40.05% +40.05% 1 Month +10.74% +10.74% 3 Month +42.76% +42.76% 6 Month +32.92% +32.92% 1 Year +19.54% +19.54% More News Read More Key Takeaways From Myriad Genetics Analyst Ratings June 27, 2024 Via Benzinga Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date July 09, 2024 From Myriad Genetics, Inc. Via GlobeNewswire The 3 Best Gene Editing Stocks to Buy in July 2024 July 08, 2024 Via InvestorPlace Myriad Genetics Earns 2024 Great Place To Work® Certification™ July 02, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election June 24, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests June 18, 2024 Via MarketBeat Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries June 11, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen June 04, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool June 03, 2024 From Myriad Genetics, Inc. Via GlobeNewswire QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications May 30, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting May 23, 2024 From Myriad Genetics, Inc. Via GlobeNewswire New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer May 16, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life May 10, 2024 Via InvestorPlace Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 08, 2024 Via Benzinga Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday May 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 08, 2024 Via Benzinga MYGN Stock Earnings: Myriad Genetics Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA May 07, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business May 07, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024 April 30, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor April 17, 2024 From Myriad Genetics, Inc. Via GlobeNewswire New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen April 16, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing April 09, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
